Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study

被引:1
作者
Perrotta, Fabio Massimo [1 ]
Scrivo, Rossana [2 ]
D'Angelo, Salvatore [3 ]
Scriffignano, Silvia [1 ]
Delle Sedie, Andrea [4 ]
Coates, Laura [5 ]
Lubrano, Ennio [1 ]
机构
[1] Univ Molise, Dipartimento Med & Sci Salute Vincenzo Tiberio, Via Giovanni Paolo II,C-da Tappino, I-86100 Campobasso, Italy
[2] Univ Roma, UOC Reumatol, Dipartimento Sci Clin Internist Anestesiolog & Car, Rome, Italy
[3] Rheumatol Inst Lucania IReL, Rheumatol Dept Lucania, Potenza, Italy
[4] Azienda Ospedaliero Univ Pisana, UO Reumatol, Pisa, Italy
[5] Univ Oxford, Nuffield Dept Orthopaed, Rheumatol & Musculoskeletal Sci, Oxford, England
关键词
Psoriatic arthritis; Patient-physician interaction; PEPPI; CollaboRATE; Outcome; MINIMAL DISEASE-ACTIVITY; PERCEIVED EFFICACY; OUTCOME MEASURE; VALIDATION; INSTRUMENT; QUESTIONNAIRE; REMISSION;
D O I
10.1007/s40744-024-00655-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionAn overarching principle for the management of psoriatic arthritis (PsA) is a shared decision-making process between physicians and patients. The aim of this study is to assess the patient-physician relationship in a group of patients with PsA, by using the Perceived Efficacy in Patient-Physician Interactions (PEPPI) and CollaboRATE instruments.MethodsThis is a cross-sectional multicenter study where consecutive patients with PsA were enrolled. For each patient, the main demographic, comorbid conditions, and clinical data were collected, including the assessment of disease activity, function, quality of life, and impact of disease. PEPPI and CollaboRATE questionnaires were used, respectively, to evaluate the patient's perception of the patient-physician relationship and the shared decision-making process.ResultsA total of 81 patients with PsA were enrolled at four centers in Italy. Overall, our patients showed a high level of confidence in obtaining needed health care, with relatively high median (IQR) values of PEPPI (20; 16-23), and a good shared decision-making process, with high median (IQR) values of CollaboRATE questionnaire (7; 6-9). PEPPI and CollaboRATE scores showed a statistically significant inverse correlation with different clinical variables such as disease duration, Leeds Enthesitis Index, PsA impact of Disease, Health Assessment Questionnaire, pain, patient's global assessment of disease activity and clinical disease activity for PsA. The presence of comorbidities did not appear to be associated with lower values of PEPPI and CollaboRATE.ConclusionsIn this study, few patients with PsA were at risk of suboptimal communication with their physician. This phenomenon appeared to be primarily related to higher disease activity and burden.
引用
收藏
页码:737 / 753
页数:10
相关论文
共 24 条
  • [1] Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
    Coates, L. C.
    Fransen, J.
    Helliwell, P. S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 48 - 53
  • [2] Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey
    Coates, Laura C.
    Azevedo, Valderilio F.
    Cappelleri, Joseph C.
    Moser, Jade
    Eder, Lihi
    Richette, Pascal
    Weng, Meng-Yu
    Silva, Ruben Queiro
    Garg, Amit
    Majjhoo, Amar
    Griffiths, Christopher E. M.
    Young, Pamela
    Howland, Samantha
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1741 - 1758
  • [3] Developing CollaboRATE: A fast and frugal patient-reported measure of shared decision making in clinical encounters
    Elwyn, Glyn
    Barr, Paul James
    Grande, Stuart W.
    Thompson, Rachel
    Walsh, Thom
    Ozanne, Elissa M.
    [J]. PATIENT EDUCATION AND COUNSELING, 2013, 93 (01) : 102 - 107
  • [4] Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control
    Furst, Daniel E.
    Melody Tran
    Sullivan, Emma
    Pike, James
    Piercy, James
    Herrera, Vivian
    Palmer, Jacqueline B.
    [J]. CLINICAL RHEUMATOLOGY, 2017, 36 (09) : 2045 - 2054
  • [5] EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
    Gossec, Laure
    Baraliakos, Xenofon
    Kerschbaumer, Andreas
    de Wit, Maarten
    McInnes, Iain
    Dougados, Maxime
    Primdahl, Jette
    McGonagle, Dennis G.
    Aletaha, Daniel
    Balanescu, Andra
    Balint, Peter V.
    Bertheussen, Heidi
    Boehncke, Wolf-Henning
    Burmester, Gerd R.
    Canete, Juan D.
    Damjanov, Nemanja S.
    Kragstrup, Tue Wenzel
    Kvien, Tore K.
    Landewe, Robert B. M.
    Lories, Rik Jozef Urbain
    Marzo-Ortega, Helena
    Poddubnyy, Denis
    Rodrigues Manica, Santiago Andres
    Schett, Georg
    Veale, Douglas J.
    Van den Bosch, Filip E.
    van der Heijde, Desiree
    Smolen, Josef S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) : 700 - 712
  • [6] A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative
    Gossec, Laure
    de Wit, Maarten
    Kiltz, Uta
    Braun, Juergen
    Kalyoncu, Umut
    Scrivo, Rossana
    Maccarone, Mara
    Carton, Laurence
    Otsa, Kati
    Sooaeaer, Imre
    Heiberg, Turid
    Bertheussen, Heidi
    Canete, Juan D.
    Lombarte, Anselm Sanchez
    Balanescu, Andra
    Dinte, Alina
    de Vlam, Kurt
    Smolen, Josef S.
    Stamm, Tanja
    Niedermayer, Dora
    Bekes, Gabor
    Veale, Douglas
    Helliwell, Philip
    Parkinson, Andrew
    Luger, Thomas
    Kvien, Tore K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 1012 - 1019
  • [7] Measuring clinical enthesitis in psoriatic arthritis: Assessment of existing measures and development of an instrument specific to psoriatic arthritis
    Healy, Paul J.
    Helliwell, Philip S.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (05): : 686 - 691
  • [8] TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis
    Lubrano, Ennio
    Scriffignano, Silvia
    Perrotta, Fabio Massimo
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (12) : 1303 - 1312
  • [9] Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors
    Lubrano, Ennio
    Parsons, Wendy J.
    Perrotta, Fabio Massimo
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (05) : 918 - 923
  • [10] Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis
    Lubrano, Ennio
    Perrotta, Fabio Massimo
    [J]. DRUGS, 2016, 76 (06) : 663 - 673